BUSINESS
Meiji Reaffirms 2028 Launch Plan for New Vaccine Site as METI Grants Finalized
Meiji Seika Pharma on April 15 reaffirmed its plan to build a new vaccine plant in Kanagawa Prefecture, south of Tokyo, and launch its operations in 2028 after the industry ministry officially approved this project for its subsidy program. The…
To read the full story
Related Article
BUSINESS
- Enhertu Accepted for EU Review in Post-Neoadjuvant HER2 Breast Cancer
February 20, 2026
- SymBio Receives Grant for Antiviral Brincidofovir
February 20, 2026
- Over 40% of Breast Surgeons Largely Unaware of Clinical Trials: Survey
February 20, 2026
- Asahi Kasei’s Flagship Teribone to Undergo US Feasibility Review by MAIA
February 20, 2026
- Asahi Kasei, Alchemedicine Begin PI Trial of CKD Drug
February 20, 2026
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…





